← Back to Clinical Trials
Recruiting NCT06444971

NCT06444971 Effects of Post-isometric Relaxation Technique on Chest Expansion and Pulmonary Function Tests in Smokers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06444971
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Tobacco Smoking
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2023-03-07
Primary Completion 2024-06-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Post isometric Relaxation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2023-03-07 with a primary completion date of 2024-06-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary objective of the study was to investigate the immediate effects of PIR technique on chest expansion and pulmonary functions in cigarette smokers.This quasi-experimental pre-test post-test study will be conducted. Participants of interest would be approached and explained about the research. Informed written consent will be taken. Recruited participants will receive PIR technique on assessory respiratory muscles and chest expansion and pulmonary function tests will be obtained before and after the treatment. Data collection tools for this study are spirometer and measuring tape.

Eligibility Criteria

Inclusion Criteria: * Individuals between the ages of 18-60 * Only tobacco cigarette smokers * Cigarette smokers (with min 2 pack years ) * Both males and females Exclusion Criteria: * Patients undergoing any surgery * Symptomatic patients of cystic fibrosis, asthma, exercise induced asthma, unstable angina, bronchitis , bronchiectasis, chest deformities, congenital cardiopulmonary disorders , disc herniation, current rib or vertebral fracture * Patients with a positive history of trauma, fracture or surgery of the cervical and thoracic spine in the last 12 months

Contact & Investigator

Central Contact

Huma Masood, MS-MSKPT*

✉ humakhalid603@gmail.com

📞 03485289948

Frequently Asked Questions

Who can join the NCT06444971 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Tobacco Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06444971 currently recruiting?

Yes, NCT06444971 is actively recruiting participants. Contact the research team at humakhalid603@gmail.com for enrollment information.

Where is the NCT06444971 trial being conducted?

This trial is being conducted at Rawalpindi, Pakistan.

Who is sponsoring the NCT06444971 clinical trial?

NCT06444971 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology